Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3092% above fair value
$88.81+0.19 (+0.21%)
Close on Nov 12, 2026Market cap $15.12BP/E 99.8Yield –
Solventum profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Solventum's profit margin for the twelve months ending Sep 30, 2026 was 1.9%. For fiscal 2025 it was 18.7%, against 5.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.7% | +12.9 |
| FY2024 | Dec 31, 2024 | 5.8% | −10.6 |
| FY2023 | Dec 31, 2023 | 16.4% | −0.1 |
| FY2022 | Dec 31, 2022 | 16.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -0.6% | −61.0 |
| Q2 FY2026 | Jun 30, 2026 | 4.2% | +0.0 |
| Q1 FY2026 | Mar 31, 2026 | 0.6% | −6.0 |
| Q4 FY2025 | Dec 31, 2025 | 3.2% | +1.7 |
| Q3 FY2025 | Sep 30, 2025 | 60.4% | +54.5 |
| Q2 FY2025 | Jun 30, 2025 | 4.2% | −0.1 |
| Q1 FY2025 | Mar 31, 2025 | 6.6% | −5.1 |
| Q4 FY2024 | Dec 31, 2024 | 1.5% | −11.9 |
| Q3 FY2024 | Sep 30, 2024 | 5.9% | −16.3 |
| Q2 FY2024 | Jun 30, 2024 | 4.3% | −11.2 |
| Q1 FY2024 | Mar 31, 2024 | 11.8% | −2.8 |
| Q4 FY2023 | Dec 31, 2023 | 13.4% | – |
| Q3 FY2023 | Sep 30, 2023 | 22.2% | – |
| Q2 FY2023 | Jun 30, 2023 | 15.5% | – |
| Q1 FY2023 | Mar 31, 2023 | 14.6% | – |
See a number that looks wrong?